Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic
By Michal Ruprecht, Jacqueline Howard, CNN (CNN) — Psychedelic drugs, once pushed to the fringes of medicine, are gaining serious attention within the Trump administration as potential treatment options for people with certain mental health conditions. And they could be getting closer to receiving approval from the US Food and Drug Administration. President Donald Trump
Original Source
Read the full article at Localnews8 →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.